These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3680594)
1. Rules governing pharmaceuticals in the European Community. Sauer F; Hankin R J Clin Pharmacol; 1987 Sep; 27(9):639-46. PubMed ID: 3680594 [TBL] [Abstract][Full Text] [Related]
2. Drug safety in the European community. Sauer F Drug Saf; 1990; 5 Suppl 1():141-8. PubMed ID: 2182057 [TBL] [Abstract][Full Text] [Related]
3. [Europe and medicines: role of the EMEA]. Sauer F Ann Pharm Fr; 2000 Jul; 58(4):278-85. PubMed ID: 10915977 [TBL] [Abstract][Full Text] [Related]
4. [Registration of new medicinal products in Europe]. Singer E Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872 [TBL] [Abstract][Full Text] [Related]
5. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Borg JJ; Aislaitner G; Pirozynski M; Mifsud S Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243 [TBL] [Abstract][Full Text] [Related]
7. Medicinal products in the European Union--between harmonization and divergence. Lojko N Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998 [TBL] [Abstract][Full Text] [Related]
8. Fighting trafficking of falsified and substandard medicinal products in Russia. Fayzrakhmanov NF Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702 [TBL] [Abstract][Full Text] [Related]
9. Regulation of immunological veterinary medicinal products in the European Union. Brunko P Rev Sci Tech; 1995 Dec; 14(4):1133-41. PubMed ID: 8639951 [TBL] [Abstract][Full Text] [Related]
11. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective. Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214 [TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes. Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834 [TBL] [Abstract][Full Text] [Related]
13. Regulatory environment for allergen-specific immunotherapy. Kaul S; May S; Lüttkopf D; Vieths S Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251 [TBL] [Abstract][Full Text] [Related]
14. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States. Qu L; Zou W; Wang Y; Wang M Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689 [TBL] [Abstract][Full Text] [Related]
15. Regulatory affairs and biotechnology in Europe. II. The CPMP, "High Tech" and Multi-State procedures. Tryzelaar B Biotherapy; 1989; 1(3):179-96. PubMed ID: 2701848 [TBL] [Abstract][Full Text] [Related]
16. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union. Woodward KN J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304 [TBL] [Abstract][Full Text] [Related]
17. [The regulatory framework for complementary and alternative medicines in Europe]. Knöss W; Stolte F; Reh K Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103 [TBL] [Abstract][Full Text] [Related]